デフォルト表紙
市場調査レポート
商品コード
1693251

医療機器償還の世界市場レポート 2025年

Medical Devices Reimbursement Global Market Report 2025


出版日
ページ情報
英文 200 Pages
納期
2~10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
医療機器償還の世界市場レポート 2025年
出版日: 2025年03月04日
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

医療機器償還市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR9.1%で9,248億3,000万米ドルに成長します。予測期間の成長は、価値ベースのヘルスケアモデル、精密医療に対する需要の高まり、世界の医療安全保障への取り組み、患者中心のケアへの注力、医療技術評価(HTA)との連携、ヘルスケアへの政府投資などに起因すると考えられます。予測期間における主な動向としては、デジタルヘルス技術の統合、メーカーと支払者の協業契約、実世界のエビデンスと医療経済データの重視、成果報酬モデルの採用、価値評価フレームワークの導入、リスク分担契約の進展などが挙げられます。

低侵襲手術への需要の高まりは、医療機器償還市場の成長を促進すると予想されます。低侵襲手術(MIS)は、従来の開腹手術に比べ、患者の体への障害を少なくして手術を行うために、特殊な技術や道具を使用する医療アプローチです。低侵襲手術に対する医療機器の償還は、高度な手技への患者アクセスの向上や、入院期間の短縮によるヘルスケアコストの削減といったメリットをもたらします。例えば、米国を拠点とする米国形成外科学会(ASPS)は2023年9月、A型ボツリヌス毒素(ボトックス、ディスポート、ゼオミンを含む)を使用した低侵襲手術が2023年に471万5716件行われ、前年から6%増加したと報告しました。さらに、皮膚充填剤が広く使用され、3,441,534件の施術が行われ、2022年から4%増加しました。したがって、低侵襲手術に対する需要の高まりが、医療機器償還市場の成長を後押ししています。

慢性疾患の増加は、医療機器償還市場の成長を促進すると予想されます。慢性疾患は、管理はできても完治はできない長期的な疾患です。医療機器の償還は、経済的負担を軽減すると同時に、アクセシビリティを確保し、イノベーションを促進し、患者の転帰を改善することで、慢性疾患の管理に重要な役割を果たしています。例えば、2024年9月、英国を拠点とする心臓・循環器系疾患に特化した慈善団体である英国心臓財団(British Heart Foundation)は、英国では約760万人がこのような疾患を抱えて生活していると報告しました。この数は2030年までに100万人、2040年までに200万人増加すると予測されています。したがって、慢性疾患の有病率の増加が医療機器償還市場の成長を促進しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、コロナ、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界医療機器償還PESTEL分析(政治、社会、技術、環境、法的要因、促進要因、抑制要因)
  • 最終用途産業の分析
  • 世界の医療機器償還市場:成長率分析
  • 世界の医療機器償還市場の実績:規模と成長, 2019-2024
  • 世界の医療機器償還市場の予測:規模と成長, 2024-2029, 2034F
  • 世界医療機器償還総アドレス可能市場(TAM)

第6章 市場セグメンテーション

  • 世界の医療機器償還市場支払者別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 公共
  • プライベート
  • 世界の医療機器償還市場クレームによる、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 低賃金
  • 満杯
  • 世界の医療機器償還市場ヘルスケア現場別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 病院
  • 外来施設
  • その他のヘルスケア現場
  • 世界の医療機器償還市場、パブリックのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 政府の健康保険プログラム
  • 国民保健サービス
  • 社会健康保険
  • 世界の医療機器償還市場、プライベートのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 民間健康保険プラン
  • 雇用主が提供する健康保険
  • 自己負担金の払い戻し

第7章 地域別・国別分析

  • 世界の医療機器償還市場:地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 世界の医療機器償還市場:国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 医療機器償還市場:競合情勢
  • 医療機器償還市場:企業プロファイル
    • UnitedHealth Group Overview, Products and Services, Strategy and Financial Analysis
    • CVS Health Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Cigna Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Anthem Insurance Companies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Axa S.A. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

  • Assicurazioni Generali SpA
  • Humana Inc.
  • Reliance Nippon Life Insurance Company Limited
  • MetLife Services and Solutions LLC
  • Aetna Inc.
  • New York Life Insurance
  • Nationwide Mutual Insurance Company
  • American International Group Inc.
  • Allstate Insurance Company
  • BNP Paribas S.A.
  • Zurich Insurance Group Ltd.
  • Aegon Life Insurance Company
  • Aviva plc
  • WellCare Health Plans Inc.
  • Pacific Life Insurance Company

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

  • 医療機器償還市場2029:新たな機会を提供する国
  • 医療機器償還市場2029:新たな機会を提供するセグメント
  • 医療機器償還市場2029:成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第36章 付録

目次
Product Code: r28491

Medical device reimbursement is the procedure through which healthcare providers receive payment from insurance plans or payers for supplying patients with medically necessary devices. This entails assessing the device's cost, evaluating its efficacy, and engaging in negotiations with payers to secure insurance coverage.

The primary contributors to medical device reimbursement are public and private entities. Public payers refer to government-funded organizations or entities tasked with financing and overseeing healthcare services for a designated population or country. Hospitals, outpatient facilities, and various healthcare settings submit claims for both underpaid and fully reimbursed services.

The medical device reimbursement market research report is one of a series of new reports from The Business Research Company that provides medical device reimbursement market statistics, including medical device reimbursement industry global market size, regional shares, competitors with a medical device reimbursement market share, detailed medical device reimbursement market segments, market trends and opportunities, and any further data you may need to thrive in the medical device reimbursement industry. This medical device reimbursement market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The medical devices reimbursement market size has grown strongly in recent years. It will grow from $602.26 billion in 2024 to $653.64 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to government healthcare policies, increased disease burden, patient access and affordability, healthcare cost containment, provider and payer collaboration, increasing regulatory compliance.

The medical devices reimbursement market size is expected to see strong growth in the next few years. It will grow to $924.83 billion in 2029 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to value-based healthcare models, rising demand for precision medicine, global health security initiatives, focus on patient-centric care, collaboration with health technology assessment (hta), government investments in healthcare. Major trends in the forecast period include integration of digital health technologies, collaborative agreements between manufacturers and payers, focus on real-world evidence and health economics data, adoption of pay-for-performance models, value assessment frameworks implementation, advancements in risk-sharing agreements.

The increasing demand for minimally invasive surgeries is expected to drive the growth of the medical device reimbursement market. Minimally invasive surgery (MIS) is a medical approach that uses specialized techniques and tools to perform surgeries with less disruption to the patient's body compared to traditional open surgery. Medical device reimbursement for minimally invasive surgeries offers benefits such as improved patient access to advanced procedures and reduced healthcare costs through shorter hospital stays. For example, in September 2023, the American Society of Plastic Surgeons (ASPS), a US-based organization, reported that 4,715,716 minimally invasive procedures using botulinum toxin type A (including Botox, Dysport, and Xeomin) were performed in 2023, marking a 6% increase from the previous year. Additionally, dermal fillers were widely used, with 3,441,534 procedures performed, reflecting a 4% rise from 2022. Therefore, the rising demand for minimally invasive surgeries is fueling the growth of the medical device reimbursement market.

The increasing prevalence of chronic diseases is expected to drive the growth of the medical device reimbursement market. Chronic diseases are long-term conditions that can be managed but not cured. Reimbursement for medical devices plays a crucial role in managing chronic diseases by ensuring accessibility, fostering innovation, and improving patient outcomes, while also reducing economic burdens. For instance, in September 2024, the British Heart Foundation, a UK-based charity focused on heart and circulatory diseases, reported that about 7.6 million people in the UK are living with such conditions. This number is projected to rise by 1 million by 2030 and by 2 million by 2040. Therefore, the increasing prevalence of chronic diseases is driving the growth of the medical device reimbursement market.

Major players in the medical device reimbursement market are strategically focusing on technological advancements, exemplified by the development of electronic medical records (EMRs), to maintain their market positions. Electronic medical records serve as digital versions of a patient's paper medical charts and play a crucial role in supporting reimbursement claims by ensuring the medical necessity and appropriate utilization of devices. For instance, in April 2023, Wemex Corporation, a Japan-based IT solutions company, introduced the medicom-HRf hybrid cloud, an integrated EMR system utilizing cloud technology to facilitate location-free operations for clinics. Hybrid cloud solutions such as Medicom-HRf seamlessly integrate various data sources, including patient records, medical billing, insurance claims, and regulatory information. This integration offers a comprehensive view of a patient's treatment and billing history, crucial for accurate reimbursement. Medical device companies can leverage such systems to access up-to-date information on insurance coverage, reimbursement rates, and claim status.

In January 2022, Centene Corporation, a US-based managed care company, completed the acquisition of Magellan Health Inc. for an undisclosed amount. This strategic move enables Centene Corporation to deliver innovative and integrated healthcare solutions, resulting in improved health outcomes at lower costs, particularly for complex and high-cost health treatments. Magellan Health Inc., as a managed care company, brings expertise in offering solutions for health plans and reimbursement management, covering a spectrum of devices and healthcare services within the healthcare landscape.

Major companies operating in the medical devices reimbursement market report are UnitedHealth Group, CVS Health Corporation, Cigna Corporation, Anthem Insurance Companies Inc., Axa S.A., Assicurazioni Generali SpA, Humana Inc., Reliance Nippon Life Insurance Company Limited, MetLife Services and Solutions LLC, Aetna Inc., New York Life Insurance, Nationwide Mutual Insurance Company, American International Group Inc., Allstate Insurance Company, BNP Paribas S.A., Zurich Insurance Group Ltd., Aegon Life Insurance Company, Aviva PLC, WellCare Health Plans Inc., Pacific Life Insurance Company, Allianz SE, Bright House Financial Inc., Globe Life Inc., Munich Re Group, Symetra Life Insurance Company, Sumitomo Life Insurance Company, NAMSA Inc., Colonial Penn Life Insurance Company, Musculoskeletal Clinical Regulatory Advisers LLC, Assurity Life Insurance

North America was the largest region in the medical devices reimbursement market in 2024. The regions covered in the medical devices reimbursement market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the medical devices reimbursement market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The medical devices reimbursement market includes revenues earned by entities by providing services such as coding and billing services, claims processing, coverage determination, benefit verification, coding and billing training, and pre-authorization and pre-certification. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Medical Devices Reimbursement Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on medical devices reimbursement market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for medical devices reimbursement ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The medical devices reimbursement market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Payer: Public; Private
  • 2) By Claims: Underpaid; Full
  • 3) By Healthcare Setting: Hospitals; Outpatient Facilities; Other Healthcare Settings
  • Subsegments:
  • 1) By Public: Government Health Insurance Programs; National Health Services; Social Health Insurance
  • 2) By Private: Private Health Insurance Plans; Employer-Sponsored Health Insurance; Out-of-Pocket Reimbursement
  • Companies Mentioned: UnitedHealth Group; CVS Health Corporation; Cigna Corporation; Anthem Insurance Companies Inc.; Axa S.A.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Medical Devices Reimbursement Market Characteristics

3. Medical Devices Reimbursement Market Trends And Strategies

4. Medical Devices Reimbursement Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Medical Devices Reimbursement Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Medical Devices Reimbursement PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Medical Devices Reimbursement Market Growth Rate Analysis
  • 5.4. Global Medical Devices Reimbursement Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Medical Devices Reimbursement Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Medical Devices Reimbursement Total Addressable Market (TAM)

6. Medical Devices Reimbursement Market Segmentation

  • 6.1. Global Medical Devices Reimbursement Market, Segmentation By Payer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Public
  • Private
  • 6.2. Global Medical Devices Reimbursement Market, Segmentation By Claims, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Underpaid
  • Full
  • 6.3. Global Medical Devices Reimbursement Market, Segmentation By Healthcare Setting, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Outpatient Facilities
  • Other Healthcare Settings
  • 6.4. Global Medical Devices Reimbursement Market, Sub-Segmentation Of Public, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Government Health Insurance Programs
  • National Health Services
  • Social Health Insurance
  • 6.5. Global Medical Devices Reimbursement Market, Sub-Segmentation Of Private, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Private Health Insurance Plans
  • Employer-Sponsored Health Insurance
  • Out-of-Pocket Reimbursement

7. Medical Devices Reimbursement Market Regional And Country Analysis

  • 7.1. Global Medical Devices Reimbursement Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Medical Devices Reimbursement Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Medical Devices Reimbursement Market

  • 8.1. Asia-Pacific Medical Devices Reimbursement Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Medical Devices Reimbursement Market, Segmentation By Payer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Medical Devices Reimbursement Market, Segmentation By Claims, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Medical Devices Reimbursement Market, Segmentation By Healthcare Setting, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Medical Devices Reimbursement Market

  • 9.1. China Medical Devices Reimbursement Market Overview
  • 9.2. China Medical Devices Reimbursement Market, Segmentation By Payer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Medical Devices Reimbursement Market, Segmentation By Claims, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Medical Devices Reimbursement Market, Segmentation By Healthcare Setting, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Medical Devices Reimbursement Market

  • 10.1. India Medical Devices Reimbursement Market, Segmentation By Payer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Medical Devices Reimbursement Market, Segmentation By Claims, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Medical Devices Reimbursement Market, Segmentation By Healthcare Setting, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Medical Devices Reimbursement Market

  • 11.1. Japan Medical Devices Reimbursement Market Overview
  • 11.2. Japan Medical Devices Reimbursement Market, Segmentation By Payer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Medical Devices Reimbursement Market, Segmentation By Claims, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Medical Devices Reimbursement Market, Segmentation By Healthcare Setting, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Medical Devices Reimbursement Market

  • 12.1. Australia Medical Devices Reimbursement Market, Segmentation By Payer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Medical Devices Reimbursement Market, Segmentation By Claims, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Medical Devices Reimbursement Market, Segmentation By Healthcare Setting, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Medical Devices Reimbursement Market

  • 13.1. Indonesia Medical Devices Reimbursement Market, Segmentation By Payer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Medical Devices Reimbursement Market, Segmentation By Claims, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Medical Devices Reimbursement Market, Segmentation By Healthcare Setting, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Medical Devices Reimbursement Market

  • 14.1. South Korea Medical Devices Reimbursement Market Overview
  • 14.2. South Korea Medical Devices Reimbursement Market, Segmentation By Payer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Medical Devices Reimbursement Market, Segmentation By Claims, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Medical Devices Reimbursement Market, Segmentation By Healthcare Setting, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Medical Devices Reimbursement Market

  • 15.1. Western Europe Medical Devices Reimbursement Market Overview
  • 15.2. Western Europe Medical Devices Reimbursement Market, Segmentation By Payer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Medical Devices Reimbursement Market, Segmentation By Claims, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Medical Devices Reimbursement Market, Segmentation By Healthcare Setting, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Medical Devices Reimbursement Market

  • 16.1. UK Medical Devices Reimbursement Market, Segmentation By Payer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Medical Devices Reimbursement Market, Segmentation By Claims, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Medical Devices Reimbursement Market, Segmentation By Healthcare Setting, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Medical Devices Reimbursement Market

  • 17.1. Germany Medical Devices Reimbursement Market, Segmentation By Payer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Medical Devices Reimbursement Market, Segmentation By Claims, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Medical Devices Reimbursement Market, Segmentation By Healthcare Setting, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Medical Devices Reimbursement Market

  • 18.1. France Medical Devices Reimbursement Market, Segmentation By Payer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Medical Devices Reimbursement Market, Segmentation By Claims, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Medical Devices Reimbursement Market, Segmentation By Healthcare Setting, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Medical Devices Reimbursement Market

  • 19.1. Italy Medical Devices Reimbursement Market, Segmentation By Payer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Medical Devices Reimbursement Market, Segmentation By Claims, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Medical Devices Reimbursement Market, Segmentation By Healthcare Setting, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Medical Devices Reimbursement Market

  • 20.1. Spain Medical Devices Reimbursement Market, Segmentation By Payer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Medical Devices Reimbursement Market, Segmentation By Claims, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Medical Devices Reimbursement Market, Segmentation By Healthcare Setting, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Medical Devices Reimbursement Market

  • 21.1. Eastern Europe Medical Devices Reimbursement Market Overview
  • 21.2. Eastern Europe Medical Devices Reimbursement Market, Segmentation By Payer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Medical Devices Reimbursement Market, Segmentation By Claims, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Medical Devices Reimbursement Market, Segmentation By Healthcare Setting, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Medical Devices Reimbursement Market

  • 22.1. Russia Medical Devices Reimbursement Market, Segmentation By Payer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Medical Devices Reimbursement Market, Segmentation By Claims, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Medical Devices Reimbursement Market, Segmentation By Healthcare Setting, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Medical Devices Reimbursement Market

  • 23.1. North America Medical Devices Reimbursement Market Overview
  • 23.2. North America Medical Devices Reimbursement Market, Segmentation By Payer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Medical Devices Reimbursement Market, Segmentation By Claims, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Medical Devices Reimbursement Market, Segmentation By Healthcare Setting, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Medical Devices Reimbursement Market

  • 24.1. USA Medical Devices Reimbursement Market Overview
  • 24.2. USA Medical Devices Reimbursement Market, Segmentation By Payer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Medical Devices Reimbursement Market, Segmentation By Claims, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Medical Devices Reimbursement Market, Segmentation By Healthcare Setting, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Medical Devices Reimbursement Market

  • 25.1. Canada Medical Devices Reimbursement Market Overview
  • 25.2. Canada Medical Devices Reimbursement Market, Segmentation By Payer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Medical Devices Reimbursement Market, Segmentation By Claims, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Medical Devices Reimbursement Market, Segmentation By Healthcare Setting, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Medical Devices Reimbursement Market

  • 26.1. South America Medical Devices Reimbursement Market Overview
  • 26.2. South America Medical Devices Reimbursement Market, Segmentation By Payer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Medical Devices Reimbursement Market, Segmentation By Claims, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Medical Devices Reimbursement Market, Segmentation By Healthcare Setting, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Medical Devices Reimbursement Market

  • 27.1. Brazil Medical Devices Reimbursement Market, Segmentation By Payer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Medical Devices Reimbursement Market, Segmentation By Claims, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Medical Devices Reimbursement Market, Segmentation By Healthcare Setting, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Medical Devices Reimbursement Market

  • 28.1. Middle East Medical Devices Reimbursement Market Overview
  • 28.2. Middle East Medical Devices Reimbursement Market, Segmentation By Payer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Medical Devices Reimbursement Market, Segmentation By Claims, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Medical Devices Reimbursement Market, Segmentation By Healthcare Setting, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Medical Devices Reimbursement Market

  • 29.1. Africa Medical Devices Reimbursement Market Overview
  • 29.2. Africa Medical Devices Reimbursement Market, Segmentation By Payer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Medical Devices Reimbursement Market, Segmentation By Claims, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Medical Devices Reimbursement Market, Segmentation By Healthcare Setting, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Medical Devices Reimbursement Market Competitive Landscape And Company Profiles

  • 30.1. Medical Devices Reimbursement Market Competitive Landscape
  • 30.2. Medical Devices Reimbursement Market Company Profiles
    • 30.2.1. UnitedHealth Group Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. CVS Health Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Cigna Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Anthem Insurance Companies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Axa S.A. Overview, Products and Services, Strategy and Financial Analysis

31. Medical Devices Reimbursement Market Other Major And Innovative Companies

  • 31.1. Assicurazioni Generali SpA
  • 31.2. Humana Inc.
  • 31.3. Reliance Nippon Life Insurance Company Limited
  • 31.4. MetLife Services and Solutions LLC
  • 31.5. Aetna Inc.
  • 31.6. New York Life Insurance
  • 31.7. Nationwide Mutual Insurance Company
  • 31.8. American International Group Inc.
  • 31.9. Allstate Insurance Company
  • 31.10. BNP Paribas S.A.
  • 31.11. Zurich Insurance Group Ltd.
  • 31.12. Aegon Life Insurance Company
  • 31.13. Aviva plc
  • 31.14. WellCare Health Plans Inc.
  • 31.15. Pacific Life Insurance Company

32. Global Medical Devices Reimbursement Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Medical Devices Reimbursement Market

34. Recent Developments In The Medical Devices Reimbursement Market

35. Medical Devices Reimbursement Market High Potential Countries, Segments and Strategies

  • 35.1 Medical Devices Reimbursement Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Medical Devices Reimbursement Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Medical Devices Reimbursement Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer